Subscribe for email alerts
Donate to Science & Enterprise
|
By Alan, on August 22nd, 2023%
A company creating a digital process to monitor farm insect pests is receiving funds to expand its technology for tracking and counting mosquitoes as a general public health threat. . . . → Read More: Small Biz Award Funds A.I. Mosquito Monitoring System
By Alan, on July 24th, 2023%
A digital health company with an app for monitoring maternal health is receiving nearly $1 million to add an algorithm for detecting a dangerous pregnancy complication. . . . → Read More: Small Biz Award to Boost Maternal Health App
By Alan, on June 14th, 2023%
A company detecting early-stage crop diseases with handheld devices and artificial intelligence is raising $3.5 million in its seed venture round. . . . → Read More: Crop Health Device Company Raises $3.5M in Early Funds
By Alan, on June 12th, 2023%
A developer of fusion energy for space travel and software company for space flight systems are writing machine learning algorithms to design a hyper-fast rocket engine. . . . → Read More: Companies Partner on A.I., Fusion Energy for Space Flight
By Alan, on May 6th, 2023%
Technology intelligence company CB Insights says this week that psychedelic therapies and services are generating little interest among venture investors this year, with only nine deals totaling $21 million. . . . → Read More: Infographic – Psychedelics Funding Coming Down
By Alan, on April 26th, 2023%
A study of insurance claims records matching the design of randomized clinical trials shows claims data can in some cases resemble clinical trial results to make causal inferences. . . . → Read More: Real World Evidence Shown to Emulate Some Clinical Trials
By Alan, on March 22nd, 2023%
A new company making antibodies that degrade disease-causing proteins on and outside cell surfaces is raising $50 million in its first venture funding round. . . . → Read More: Start-Up Licenses Protein Therapy Tech, Raises $50M
By Alan, on March 21st, 2023%
A developer of mental health therapies from psychedelic compounds says it received FDA clearance for a clinical trial testing low doses of psilocybin. . . . → Read More: Trial to Test Low-Dose Psilocybin for Mental Distress
By Alan, on February 16th, 2023%
A start-up enterprise, spun-off from Tufts University labs, creating bio-electrical treatments for regenerating limbs and tissue, is raising $8 million in new seed funds. . . . → Read More: Bio-Electric Regeneration Company Adds $8M in Seed Funds
By Alan, on February 2nd, 2023%
A new company creating precision light-activated treatments for autism spectrum disorder symptoms is raising more seed funds and joining a start-up incubator program. . . . → Read More: Autism Device Company Gains Venture Funds, Joins Incubator
|
Welcome to Science & Enterprise Science and Enterprise is an online news service begun in 2010, created for researchers and business people interested in taking scientific knowledge to the marketplace.
On the site’s posts published six days a week, you find research discoveries destined to become new products and services, as well as news about finance, intellectual property, regulations, and employment.
|